BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 22138325)

  • 1. Epistatic effects between variants of kappa-opioid receptor gene and A118G of mu-opioid receptor gene increase susceptibility to addiction in Indian population.
    Kumar D; Chakraborty J; Das S
    Prog Neuropsychopharmacol Biol Psychiatry; 2012 Mar; 36(2):225-30. PubMed ID: 22138325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. κ Opioid Receptor 1 Single Nucleotide Polymorphisms were Associated with the Methadone Dosage.
    Zhang Q; Shi M; Tang H; Zhong H; Lu X
    Genet Test Mol Biomarkers; 2020 Jan; 24(1):17-23. PubMed ID: 31940240
    [No Abstract]   [Full Text] [Related]  

  • 3. An analysis of genetic association in opioid dependence susceptibility.
    Nagaya D; Zahari Z; Saleem M; Yahaya BH; Tan SC; Yusoff NM
    J Clin Pharm Ther; 2018 Feb; 43(1):80-86. PubMed ID: 28656735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between mu opioid receptor gene polymorphisms and Chinese heroin addicts.
    Szeto CY; Tang NL; Lee DT; Stadlin A
    Neuroreport; 2001 May; 12(6):1103-6. PubMed ID: 11338173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic susceptibility to heroin addiction: a candidate gene association study.
    Levran O; Londono D; O'Hara K; Nielsen DA; Peles E; Rotrosen J; Casadonte P; Linzy S; Randesi M; Ott J; Adelson M; Kreek MJ
    Genes Brain Behav; 2008 Oct; 7(7):720-9. PubMed ID: 18518925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence variations in the mu-opioid receptor gene (OPRM1) associated with human addiction to heroin.
    Shi J; Hui L; Xu Y; Wang F; Huang W; Hu G
    Hum Mutat; 2002 Apr; 19(4):459-60. PubMed ID: 11933204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A heroin addiction severity-associated intronic single nucleotide polymorphism modulates alternative pre-mRNA splicing of the μ opioid receptor gene OPRM1 via hnRNPH interactions.
    Xu J; Lu Z; Xu M; Pan L; Deng Y; Xie X; Liu H; Ding S; Hurd YL; Pasternak GW; Klein RJ; Cartegni L; Zhou W; Pan YX
    J Neurosci; 2014 Aug; 34(33):11048-66. PubMed ID: 25122903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A118g polymorphism in mu opioid receptor gene (oprm1): association with opiate addiction in subjects of Indian origin.
    Kapur S; Sharad S; Singh RA; Gupta AK
    J Integr Neurosci; 2007 Dec; 6(4):511-22. PubMed ID: 18181266
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of CREB1 gene polymorphism with drug seeking behaviour in eastern Indian addicts.
    Pal A; Chakraborty J; Das S
    Neurosci Lett; 2014 Jun; 570():53-7. PubMed ID: 24704376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyses of polymorphisms of intron 2 of OPRK1 (kappa-opioid receptor gene) in association with opioid and cocaine dependence diagnoses in an African-American population.
    Yuferov V; Butelman ER; Randesi M; Ott J; Kreek MJ
    Neurosci Lett; 2022 Jan; 768():136364. PubMed ID: 34843875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic association analyses and meta-analysis of Dynorphin-Kappa Opioid system potential functional variants with heroin dependence.
    Yuanyuan J; Rui S; Hua T; Jingjing C; Cuola D; Yuhui S; Shuguang W
    Neurosci Lett; 2018 Oct; 685():75-82. PubMed ID: 30138645
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction.
    Bond C; LaForge KS; Tian M; Melia D; Zhang S; Borg L; Gong J; Schluger J; Strong JA; Leal SM; Tischfield JA; Kreek MJ; Yu L
    Proc Natl Acad Sci U S A; 1998 Aug; 95(16):9608-13. PubMed ID: 9689128
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [μ-Opioid Receptor Gene (OPRM1) Polymorphisms A118G and C17T in Alcohol Dependence: A Turkish Sample].
    Gürel ŞC; Ayhan Y; Karaaslan Ç; Akel H; Karaca RÖ; Babaoğlu MÖ; Yaşar Ü; Bozkurt A; Dilbaz N; Uluğ BD; Demir B
    Turk Psikiyatri Derg; 2016; 27(2):0. PubMed ID: 27370058
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-nucleotide polymorphism (A118G) in exon 1 of OPRM1 gene causes alteration in downstream signaling by mu-opioid receptor and may contribute to the genetic risk for addiction.
    Deb I; Chakraborty J; Gangopadhyay PK; Choudhury SR; Das S
    J Neurochem; 2010 Jan; 112(2):486-96. PubMed ID: 19891732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid Receptors Gene Polymorphism and Heroin Dependence in Iran.
    Soleimani Asl S; Roointan A; Bergen H; Amiri S; Mardani P; Ashtari N; Shabani R; Mehdizadeh M
    Basic Clin Neurosci; 2018; 9(2):101-106. PubMed ID: 29967669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. OPRM1, OPRK1, and COMT genetic polymorphisms associated with opioid effects on experimental pain: a randomized, double-blind, placebo-controlled study.
    Ho KWD; Wallace MR; Staud R; Fillingim RB
    Pharmacogenomics J; 2020 Jun; 20(3):471-481. PubMed ID: 31806881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human kappa opioid receptor gene (OPRK1) polymorphism is associated with opiate addiction.
    Gerra G; Leonardi C; Cortese E; D'Amore A; Lucchini A; Strepparola G; Serio G; Farina G; Magnelli F; Zaimovic A; Mancini A; Turci M; Manfredini M; Donnini C
    Am J Med Genet B Neuropsychiatr Genet; 2007 Sep; 144B(6):771-5. PubMed ID: 17373729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OPRM1 rs1799971 polymorphism and opioid dependence: evidence from a meta-analysis.
    Haerian BS; Haerian MS
    Pharmacogenomics; 2013 May; 14(7):813-24. PubMed ID: 23651028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redefinition of the human kappa opioid receptor gene (OPRK1) structure and association of haplotypes with opiate addiction.
    Yuferov V; Fussell D; LaForge KS; Nielsen DA; Gordon D; Ho A; Leal SM; Ott J; Kreek MJ
    Pharmacogenetics; 2004 Dec; 14(12):793-804. PubMed ID: 15608558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A pharmacogenetic analysis of dopaminergic and opioidergic genes in opioid addicts treated with the combination of naltrexone and guanfacine].
    Kibitov АО; Krupitsky ЕМ; Blokhina ЕА; Verbitskaya ЕV; Brodyansky VМ; Alekseeva NP; Bushara NМ; Yaroslavtseva ТS; Palatkin VY; Masalov DV; Burakov АМ; Romanova ТN; Sulimov GY; Grinenko AY; Kosten Т; Nielsen D; Zvartau EE
    Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11. Vyp. 2):36-48. PubMed ID: 28300812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.